OCT/OCTA ocular biomarkers may help diagnose Parkinson disease
Retinal and choroidal changes were observed in study.
Reviewed by Sharon Fekrat, MD, and Dilraj S. Grewal, MD
There is no single diagnostic test for Parkinson disease (PD), and neurologists often rely on the patient’s response to medications to differentiate the disease from conditions with similar symptoms.
Investigators at Duke University have taken a step toward establishing an adjunctive approach using retinal imaging to diagnose PD.
They used enhanced-depth
Related:
Cason B. Robbins, BS, of the Department of Ophthalmology at Duke University School of Medicine in Durham, North Carolina, lead author of the study, evaluated the retinal microvascular and choroidal structural changes in the eyes of patients with PD.1
Previous study results indicated that cerebral small vessel disease may be a potential risk factor for development of PD, and PD has a higher prevalence of cerebral ischemic lesions, Robbins et al noted.2-4
The study and results
Participants were enrolled at the Duke Neurological Disorders Clinic. The 69 patients (124 eyes; mean age, 71.7 years) had received an established clinical diagnosis of PD.
There were 137 cognitively healthy controls (248 eyes; mean age, 70.9 years). All patients underwent OCT and OCTA.
The investigators assessed the superficial capillary plexus vessel density (VD) and perfusion density (PFD) within the Early Treatment Diabetic Retinopathy Study (ETDRS) 6 × 6-mm circle, 6 × 6-mm inner ring, 6 × 6-mm outer ring, and the foveal avascular zone.
Related:
The investigators measured the retinal nerve fiber layer thickness, macular ganglion cell/inner plexiform layer thickness, central subfield thickness, subfoveal choroidal thickness, total choroidal area, luminal area, and choroidal vascularity index (CVI).
The results showed that compared with the healthy sex- and age-matched controls, the VD and PFD were significantly lower in the patients with PD in the 6 × 6-mm ETDRS circle (P = 0.3 and P = 0.4, respectively) and in the 6 × 6-mm inner ring (P = .003 and P = .004, respectively).
The total choroidal area and luminal area were larger in the patients with PD (P = 0.1 and P = 0.2, respectively). The CVI was lower in the patients with PD.
The results did not show differences in the retinal nerve fiber layer or ganglion cell layer thickness or the subfoveal choroidal thickness, the latter of which differs from the results of some other studies.
Related:
Robbins joined Sharon Fekrat, MD, a professor of ophthalmology at Duke University School of Medicine; Dilraj S. Grewal, MD, an associate professor of ophthalmology at Duke University School of Medicine; and the other coauthors in pointing out that the current findings are combined with the clinical history and other tests.
“These choroidal and retinal microvascular imaging findings may hold the potential to improve clinician confidence in the diagnosis of PD,” they wrote.
According to the investigators, the findings highlight the need for further research into retinal imaging as a potential novel biomarker for individuals with neurodegenerative diseases such as PD.
“Future long-term studies that characterize the natural history of microvascular and structural retinal changes in individuals across the clinical spectrum of PD [are] warranted,” they concluded. “Studies may help clarify whether these imaging findings may be useful as biomarkers for the onset of PD.”
Sharon Fekrat, MD
e: [email protected]
Fekrat has no financial interest in this subject matter.
Dilraj S. Grewal, MD
e: [email protected]
Grewal has no financial interest in this subject matter.
--
References
1. Robbins CB, Thompson AC, Bhullar PK, et al. Characterization of retinal microvascular and choroidal structural changes in Parkinson disease. JAMA Ophthalmol. 2021;139(2):182-188. doi:10.1001/jamaophthalmol.2020.5730
2. Guan J, Pavlovic D, Dalkie N, et al. Vascular degeneration in Parkinson’s disease. Brain Pathol. 2013;23(2):154-164. doi: 10.1111/j.1750-3639.2012.00628.x
3. Van deer Holst HM, van Uden IWM, Tuladhar AM, et al. Cerebral small vessel disease and incident parkinsonism: the RUN DMC study. Neurology. 2015;85(18):1569-1577. doi:10.1212/WNL.0000000000002082
4. Song IU, Lee JE, Kwon DY, Park JH, Ma HI. Parkinson’s disease might increase the risk of cerebral ischemic lesions. Int J Med Sci. 2017;14(4):319-322. doi:10.7150/ijms.18025
Articles in this issue
almost 4 years ago
Genetics give investigators a risk stratification in glaucomaalmost 4 years ago
Physicians sort out pros and cons of several new IOLs on the marketalmost 4 years ago
Technologies offer options in treatment of uveitisalmost 4 years ago
Femtosecond laser-assisted cataract surgery: One physician’s storyalmost 4 years ago
Corneal neurotization is effective for restoring sensory innervationalmost 4 years ago
Neuro-ophthalmology: More to offer than just steroidsalmost 4 years ago
Ophthalmology in the Big Easy: AAO 2021 welcomes in-person attendeesalmost 4 years ago
A closer look at presbyopia optionsalmost 4 years ago
Improving surgical outcomes for pediatric patientsNewsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Articles
- The European Commission grants marketing authorization for EYLUXVI
September 23rd 2025
- Luxa Biotechnology announces clinical trial results for treatment of AMD
September 22nd 2025
- Q&A: Anat Loewenstein recaps the 2025 EURETINA meeting
September 22nd 2025